Home › Companies › GYRE THERAPEUTICS INC. › 2024-2025
At GYRE THERAPEUTICS INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 67 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 446 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — GYRE THERAPEUTICS INC.'s filing reports the proposal as approved, with 99.9% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: GYRE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and GYRE THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 4, 2025: 5 items on GYRE THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025: 3 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore GYRE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are GYRE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Gordon Carmichael, Ph.D. | 69,249,334 | -- | -- | 297,881 | 2,778,540 | 99.5% | Elected | — |
| Elect Director: Songjiang Ma | 69,385,506 | -- | -- | 161,709 | 2,778,540 | 99.7% | Elected | — |
| Elect Director: Ping Zhang | 69,320,687 | -- | -- | 226,528 | 2,778,540 | 99.6% | Elected | — |
| 2. Non-Binding Advisory Vote on Executive Compensation The compensation of the Company's named executive officers | 69,505,961 | 39,318 | 1,936 | -- | 2,778,540 | 99.9% | Approved | — |
| 3. Ratification of Independent Auditor The appointment of Grant Thornton Zhitong Certified Public Accountants LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 72,175,754 | 3,738 | 146,263 | -- | 0 | 99.9% | Approved | — |
Source: GYRE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.
Each item below shows how the 67 asset managers that disclosed a GYRE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors for terms expiring in 2028: Gordon Carmichael, Ph.D.
GYRE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gordon Carmichael, Ph.D.”): 69,249,334 for, 297,881 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 291,996 for, 24,376 withheld, 60,621 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 178,258 | 0 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 57,423 | 0 | Abstain |
| American Century | 23,825 | 0 | 0 | 0 | For |
| Northern Trust | 12,034 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 9,910 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 5,500 | Withhold |
| Fidelity | 4,092 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 3,637 | Withhold |
| AIG/SunAmerica | 3,605 | 0 | 0 | 0 | For |
| TIAA | 3,477 | 0 | 0 | 0 | For |
| Legg Mason | 3,364 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 3,197 | 0 | Abstain |
| State Street | 0 | 0 | 0 | 2,907 | Withhold |
| Voya | 2,100 | 0 | 0 | 0 | For |
| Global X | 1,227 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 1,156 | Withhold |
| Victory Capital | 1,051 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 683 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 370 | Withhold |
| ProShares | 249 | 0 | 0 | 0 | For |
| John Hancock | 160 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 129 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 128 | Withhold |
| DWS | 111 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors for terms expiring in 2028: Ping Zhang
GYRE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ping Zhang”): 69,320,687 for, 226,528 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 316,119 for, 60,585 withheld, 289 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 178,258 | 0 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| BlackRock | 57,423 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 23,825 | Withhold |
| Northern Trust | 0 | 0 | 0 | 12,034 | Withhold |
| Equitable | 9,910 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 5,500 | Withhold |
| Fidelity | 4,092 | 0 | 0 | 0 | For |
| Pacific Life | 3,637 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 3,605 | Withhold |
| TIAA | 0 | 0 | 0 | 3,477 | Withhold |
| Legg Mason | 0 | 0 | 0 | 3,364 | Withhold |
| Bridge Builder Trust | 3,197 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 2,907 | Withhold |
| Voya | 0 | 0 | 0 | 2,100 | Withhold |
| Global X | 1,227 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 1,154 | Withhold |
| Victory Capital | 0 | 0 | 0 | 1,051 | Withhold |
| Calvert | 0 | 0 | 0 | 683 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 370 | Withhold |
| ProShares | 0 | 0 | 0 | 249 | Withhold |
| John Hancock | 0 | 0 | 160 | 0 | Abstain |
| Innovator ETFs Trust | 0 | 0 | 129 | 0 | Abstain |
| Goldman Sachs | 128 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 111 | Withhold |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors for terms expiring in 2028: Songjiang Ma
GYRE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Songjiang Ma”): 69,385,506 for, 161,709 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 335,104 for, 41,729 withheld, 160 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 178,258 | 0 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| BlackRock | 57,423 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 23,825 | Withhold |
| Northern Trust | 12,034 | 0 | 0 | 0 | For |
| Equitable | 9,910 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 5,500 | Withhold |
| Fidelity | 4,092 | 0 | 0 | 0 | For |
| Pacific Life | 3,637 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 3,605 | Withhold |
| TIAA | 3,477 | 0 | 0 | 0 | For |
| Legg Mason | 0 | 0 | 0 | 3,364 | Withhold |
| Bridge Builder Trust | 3,197 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 2,907 | Withhold |
| Voya | 2,100 | 0 | 0 | 0 | For |
| Global X | 1,227 | 0 | 0 | 0 | For |
| Nationwide | 1,156 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 1,051 | Withhold |
| Calvert | 0 | 0 | 0 | 683 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 370 | Withhold |
| ProShares | 0 | 0 | 0 | 249 | Withhold |
| John Hancock | 0 | 0 | 160 | 0 | Abstain |
| Innovator ETFs Trust | 129 | 0 | 0 | 0 | For |
| Goldman Sachs | 128 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 111 | Withhold |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
GYRE THERAPEUTICS INC.’s own tally for this item (“2. Non-Binding Advisory Vote on Executive Compensation The compensation of the Company's named executive officers”): 69,505,961 for, 39,318 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Non-Binding Advisory Vote on Executive Compensation The compensation of the Company's named executive officers was approved, on a non-binding, advisory basis, as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 178,258 | 0 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| BlackRock | 57,423 | 0 | 0 | 0 | For |
| American Century | 0 | 23,825 | 0 | 0 | Against |
| Northern Trust | 12,034 | 0 | 0 | 0 | For |
| Equitable | 9,910 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,500 | 0 | 0 | 0 | For |
| Fidelity | 4,092 | 0 | 0 | 0 | For |
| Pacific Life | 3,637 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,605 | 0 | 0 | 0 | For |
| TIAA | 3,477 | 0 | 0 | 0 | For |
| Legg Mason | 3,364 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,197 | 0 | 0 | 0 | For |
| State Street | 2,907 | 0 | 0 | 0 | For |
| Voya | 2,100 | 0 | 0 | 0 | For |
| Global X | 1,227 | 0 | 0 | 0 | For |
| Nationwide | 1,156 | 0 | 0 | 0 | For |
| Victory Capital | 1,051 | 0 | 0 | 0 | For |
| Calvert | 0 | 683 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 370 | 0 | 0 | 0 | For |
| ProShares | 249 | 0 | 0 | 0 | For |
| John Hancock | 160 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 129 | 0 | 0 | 0 | For |
| Goldman Sachs | 128 | 0 | 0 | 0 | For |
| DWS | 111 | 0 | 0 | 0 | For |
Fund voting reports, all 29 managers: 352,485 for, 24,508 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 126,516 | 4,356 | 0 | 0 | For |
| State Street | 87,744 | 243 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| Northern Trust | 44,588 | 0 | 0 | 0 | For |
| American Century | 0 | 23,825 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 18,882 | 0 | 0 | 0 | For |
| Fidelity | 10,723 | 0 | 0 | 0 | For |
| AllianceBernstein | 8,740 | 0 | 0 | 0 | For |
| Vanguard | 5,879 | 0 | 0 | 0 | For |
| Advantage Alpha Capital Partners LP | 5,418 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,807 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 4,500 | 0 | 0 | 0 | For |
| Rhumbline | 3,491 | 5 | 0 | 0 | For |
| Nuveen | 3,477 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 3,364 | 0 | 0 | 0 | For |
| JPMorgan | 3,156 | 0 | 0 | 0 | For |
| Invesco | 0 | 2,927 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,700 | 0 | 0 | 0 | For |
| Two Sigma | 2,100 | 0 | 0 | 0 | For |
| Voya | 2,100 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 1,564 | 0 | 0 | 0 | For |
| NISA INVESTMENT ADVISORS, LLC | 0 | 1,300 | 0 | 0 | Against |
| Neuberger Berman | 1,154 | 0 | 0 | 0 | For |
| Victory Capital | 1,051 | 0 | 0 | 0 | For |
| Calvert | 0 | 683 | 0 | 0 | Against |
Institutional-manager reports, all 50 managers: 403,816 for, 34,273 against, 37 abstained. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Grant Thornton Zhitong Certified Public Accountants LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
GYRE THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Independent Auditor The appointment of Grant Thornton Zhitong Certified Public Accountants LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 72,175,754 for, 3,738 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Ratification of Independent Auditor The appointment of Grant Thornton Zhitong Certified Public Accountants LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 was ratified as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 376,993 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 178,258 | 0 | 0 | 0 | For |
| Charles Schwab | 58,244 | 0 | 0 | 0 | For |
| BlackRock | 57,423 | 0 | 0 | 0 | For |
| American Century | 23,825 | 0 | 0 | 0 | For |
| Northern Trust | 12,034 | 0 | 0 | 0 | For |
| Equitable | 9,910 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,500 | 0 | 0 | 0 | For |
| Fidelity | 4,092 | 0 | 0 | 0 | For |
| Pacific Life | 3,637 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,605 | 0 | 0 | 0 | For |
| TIAA | 3,477 | 0 | 0 | 0 | For |
| Legg Mason | 3,364 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,197 | 0 | 0 | 0 | For |
| State Street | 2,907 | 0 | 0 | 0 | For |
| Voya | 2,100 | 0 | 0 | 0 | For |
| Global X | 1,227 | 0 | 0 | 0 | For |
| Nationwide | 1,156 | 0 | 0 | 0 | For |
| Victory Capital | 1,051 | 0 | 0 | 0 | For |
| Calvert | 683 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 370 | 0 | 0 | 0 | For |
| ProShares | 249 | 0 | 0 | 0 | For |
| John Hancock | 160 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 129 | 0 | 0 | 0 | For |
| Goldman Sachs | 128 | 0 | 0 | 0 | For |
| DWS | 111 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 93,757,602 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.19% |
| 2 | Charles Schwab | 0.06% |
| 3 | BlackRock | 0.06% |
| 4 | American Century | 0.03% |
| 5 | Northern Trust | 0.01% |
| 6 | Equitable | 0.01% |
| 7 | Lincoln Financial | <0.01% |
| 8 | Fidelity | <0.01% |
| 9 | Pacific Life | <0.01% |
| 10 | AIG/SunAmerica | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 0.14% |
| 2 | State Street | 0.09% |
| 3 | Charles Schwab | 0.06% |
| 4 | Northern Trust | 0.05% |
| 5 | American Century | 0.03% |
| 6 | MELLON INVESTMENTS Corp | 0.02% |
| 7 | Fidelity | 0.01% |
| 8 | AllianceBernstein | <0.01% |
| 9 | Vanguard | <0.01% |
| 10 | Advantage Alpha Capital Partners LP | <0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| GNI USA, Inc. | — | 13D |
| Ying Luo | — | 13D |
| Songjiang Ma | — | 13D |
| Vanguard Group | — | 13F |
| BlackRock | — | 13F |
| Geode Capital | — | 13F |
| State Street | — | 13F |
| Charles Schwab | — | 13F |
| Northern Trust | — | 13F |
| BNY Mellon | — | 13F |
Percentages above are of 93,757,602 shares outstanding, as reported by GYRE THERAPEUTICS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GYRE THERAPEUTICS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
GYRE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “GYRE THERAPEUTICS (GYRE) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/gyre-therapeutics-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.